What's New
Updated to incorporate all new information in Summaries of Product Characteristics to June 14, 2013, and improvements to accompanying nutritional information.
App Description
Up-to-date (to June 14, 2013) clear, concise, and consistently presented information on the safe use of angiotensin-converting enzyme (ACE) inhibitors to treat hypertension, heart disease, and diabetic kidney disease to Avoid Adverse Effects in Adults. The screens have been specially edited and designed for the iPhone and iPad and you can add your favourites to Quick Find. The interface is easy and intuitive to navigate, colour-coded, searchable, zoomable, viewable in portrait and landscape, with useful hyperlinks throughout. Compiled and edited by highly experienced medical editor, UK-registered Dr Lindy van den Berghe, BMedSci, BM, BS. All information has been checked against the Summaries of Product Characteristics (SPCs) provided for each drug by the manufacturer. Regular free updates incorporating any new information in updated SPCs will be provided. See www.AAeARx.co.uk.
iPhone Screenshots
(click to enlarge)
iPad Screenshots
(click to enlarge)
App Changes
- January 26, 2013 New version 1.2
- February 12, 2013 New version 1.3
- June 30, 2013 New version 1.4
- July 13, 2016 Price increase: $0.99 -> $1.99
Other Apps From First Line Medical Communications
